...

Dassault Systèmes Takes Its Life Sciences Ambition to the Next Level with a Unified AI Platform Connecting Science, Medicine and Patients

life sciences

Dassault Systèmes is further pursuing the strategy of the Dassault Systèmes AI Platform through completing its ArisGlobal acquisition. The firm is integrating its Life Sciences and Healthcare functions into one platform for science, medicine, and patients. Moreover, the firm named Dr. Ashwini Zenooz as the Executive Vice President and CEO of its Life Sciences and Healthcare business.

The strategic initiative is intended to accelerate drug discovery, improve therapies and make smart decisions in the healthcare space. They will combine the drug development processes with this integrated approach with the help of the Dassault Systèmes AI Platform.

“Life Sciences is reaching its own inflection point. For years, discovery, clinical development, manufacturing and patient outcomes have been separate worlds, each learning too slowly from the others. Today, we take a decisive step to change that,” said Pascal Daloz, Chief Executive Officer and Chairman of the Board, Dassault Systèmes. 

“Today our Life Sciences portfolio comes together in 3D UNIV+RSES: one AI-native enterprise platform connecting the full drug lifecycle in a continuous cycle of discovery, learning and improvement. Every step becomes more valuable because it is connected to, and informs, the others. Scientific models become smarter. Clinical trials become more informed. Manufacturing becomes more adaptive, and patient outcomes continuously improve future innovation.”

ArisGlobal Acquisition Expands Life Sciences Capabilities

The ArisGlobal acquisition was completed by Dassault Systèmes for a sum of $1.8 billion in cash. In addition, the deal consists of up to $200 million in additional consideration depending on multi-year revenue-related performance related to artificial intelligence.

ArisGlobal offers an AI-native solution for compliance, safety, quality, and medical affairs. More than 200 customers use their product and include 50 of the world’s biggest biopharmaceutical firms. As for Aman Wasan, he will continue heading the company as its CEO.

The company will join the Dassault Systèmes Life Sciences and Healthcare sector in the same way as BIOVIA and MEDIDATA do. Thus, the Dassault Systèmes AI Platform will link scientific discovery, clinical development, manufacturing, and patient outcomes.

Thanks to AI, scientific expertise, and virtual twins, the company intends to make complicated data understandable and actionable.

Dr. Ashwini Zenooz to Lead Life Sciences and Healthcare

Dr. Ashwini Zenooz is slated to oversee operations for MEDIDATA, BIOVIA, and ArisGlobal. The duties will include strategy, integration, sales, go-to-market initiatives, and strategic partnerships. In addition, her role will help facilitate collaboration in pharmaceuticals, biotechnology, medical technology, diagnostics, and digital health. In addition, her hiring comes with the objective of increasing usage of the Dassault Systèmes AI Platform.

Dr. Ashwini Zenooz’s experience encompasses being a physician, technology leader, and an entrepreneur. She has served in various capacities at Salesforce, Commure, and the U.S. Department of Veterans Affairs. Her focus is on radiology with specialization in telehealth, precision medicine, mental health, and artificial intelligence.

Building on Established Life Sciences Technologies

The Life Sciences division at Dassault Systèmes has been built up over more than a decade. BIOVIA helps in scientific simulation, while MEDIDATA has helped with 42,000 clinical trials that included 13 million patients.

The company launched its initiative for extending Virtual Twins into Life Sciences in the year 2020. This includes a combination of Biosciences, Material Sciences, and Information Sciences using the 3DEXPERIENCE platform. Eventually, the AI Platform from Dassault Systèmes seeks to bring all these capabilities together.

Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.

News Source: Businesswire.com

Share with friends

Latest News